Abstract: |
The PML gene of acute promyelocytic leukaemia (APL) encodes a growth- and tumour-suppresor protein that is essential for several apoptotic signals. The mechanisms by which PML exerts its pro-apoptotic function are still unknown. Here we show that PML acts as a transcriptional co-activator with p53. PML physically interacts with p53 both in vitro and in vivo and co-localizes with p53 in the PML nuclear body (PML-NB). The co-activatory role of PML depends on its ability to localize in the PML-NB. p53-dependent, DNA-damage-induced apoptosis, transcriptional activation by p53, the DNA-binding ability of p53, and the induction of p53 target genes such as Bax and p21 upon γ-irradiation are all impaired in PML(-/-) primary cells. These results define a new PML-dependent, p53-regulatory pathway for apoptosis and shed new light on the function of PML in tumour suppression. |
Keywords: |
signal transduction; controlled study; nonhuman; animal cell; mouse; animal; mice; dna damage; apoptosis; protein dna binding; transcription initiation; neoplasm proteins; mice, mutant strains; gene function; in vivo study; in vitro study; protein p53; transcription factors; cancer inhibition; leukemia, promyelocytic, acute; gene expression regulation, neoplastic; transcription regulation; thymus gland; promyelocytic leukemia; gamma irradiation; cell nucleus; gene induction; gamma rays; trans-activation (genetics); cell nucleus inclusion body; priority journal; article; cell compartmentation; support, non-u.s. gov't; support, u.s. gov't, p.h.s.
|